Tumour necrosis factor \g=a\(TNF-\g=a\)concentrations were measured during periods of controlled and natural follicular development and ovulation in rat ovaries. Concentrations of bioactive TNF-\g=a\were determined in the ovaries and sera of rats during puberty (the period of vaginal opening and the first ovulation) and in immature rats after gonadotrophin treatment. Ovaries and sera were collected from 33-, 35-, 37-, 39-, 41-and 43-day-old rats (n = 6 or 7 per group); vaginal opening occurs on day 35. The presence of ovarian follicles and corpora lutea or ova in the oviducts was assessed. For gonadotrophin treatment, a single subcutaneous injection of 5 iu equine chorionic gonadotrophin (eCG) was administered at 08:00 h to 28-day-old rats to stimulate follicular development. A single subcutaneous injection of 10 iu human chorionic gonadotrophin (hCG) was administered 48 h later to induce ovulation. Ovaries and sera from three to six animals per group were collected 0, 3, 24, 48, 51, 54, 57, 60 and 72 h after injection of eCG. At puberty, ovarian concentrations of TNF-\g=a\were highest (approximately 1.1 fg \ g=m\ g\ m=-\ 1 ovarian protein) before vaginal opening and the first ovulation. After vaginal opening and ovulation at day 37, ovarian concentrations of TNF-\g=a\ were markedly reduced (0.091 fg \g=m\g \ m=-\ 1 ovarian protein) and remained low up to day 43. Serum concentrations of TNF-\g=a\remained low throughout the period of vaginal opening and the first ovulation (8\p=n-\32 pg ml\m=-\1 ). In 43-day-old rats serum concentrations of TNF-\g=a\increased (105 pg ml\m=-\1 ). In the immature ovaries of 28-day-old rats TNF-\g=a\ concentrations were highest before injection of eCG (approximately 1.2 fg \ g=m\ g \m=-\1ovarian protein) and decreased to approximately 0.4 fg \g=m\g \m=-\1 protein 3 h after injection. TNF-\g=a\concentrations decreased further 24 h after eCG injection ( < 0.1 fg \ g=m\ g\ m=-\ 1 protein) and remained low until 48 h after eCG injection. Serum concentrations of TNF-\g=a\ did not change during the 48 h period after injection of eCG. hCG was administered 48 h after eCG, and ovarian and serum TNF-\g=a\concentrations increased transiently. Serum TNF-\g=a\ concentrations increased 3 h after hCG and remained elevated until 9 h after injection, after which concentrations decreased. Ovarian concentrations of TNF-\g=a\increased 6 h after hCG, peaked (approximately 0.5 fg \g=m\g \m=-\1 protein), and then declined. These results indicate that during puberty and the first ovulation, circulating and ovarian TNF-\g=a\concentrations change. In addition, exogenous gonadotrophins alter circulating and ovarian TNF-\g=a\ concentrations. These data suggest that TNF-\g=a\has a role in follicular development and ovulation during puberty and in immature rats treated with gonadotrophins to induce ovulation.
Introduction
Previous studies have revealed that the ovary contains TNFand that oocytes, granulosa cells, luteal cells, endothelial cells and macrophages are specific sites of TNF-localization (Terranova et al, 1995) . Previous studies have shown that the TNFis present in the corpora lutea of cattle (Shaw and Britt, 1995) and pigs (Wuttke et al, 1993; Hehnke-Vagnoni et al, 1995) , and that TNFincreases in corpora lutea after the onset of luteal regression in cows (Shaw and Britt, 1995) and sheep (Ji et al, 1991) . During luteal regression in cows, serum *Correspondence. concentrations of TNF-do not change (Shaw and Britt, 1995) . In rats, TNF-bioactivity is low but detectable in perfusion medium of ovulating ovaries 5 h after perfusion (Brannstrom et al, 1994) . However, to date there have been no reports of changes in ovarian or serum concentrations of TNF-during the first natural ovulation or after administration of gonado¬ trophins to induce follicular development and ovulation. There¬ fore, the aim of this study was to determine the effects of the onset of puberty and the first natural ovulation on ovarian and circulating concentrations of TNF-. In addition, the effects of ovulation induction by exogenous equine eCG and hCG on ovarian and circulating TNFconcentrations in immature rats were determined.
Materials and Methods
Sprague Dawley rats (21-day-old) were obtained from Harlan Inc. (Indianapolis, IN) and vaginal opening was assessed once a day from day 26. Vaginal opening, which is an indicator of puberty, occurs in approximately 35-day-old animals. Ovaries were collected at 09:00 h from 33-, 35-, 37-, 39-, 41-and 43-day-old rats throughout puberty. Rats were decapitated and serum and ovaries were collected under aseptic conditions. Ovaries were cleaned and the presence and developmental condition of large follicles or corpora lutea were assessed under a dissecting microscope. Oviducts were flushed with saline and the number of ova was counted. Animals examined on day 35 had not ovulated although vaginal opening had occurred in most. All animals examined on day 37 had ova present in the oviducts indicating ovulation had occurred on day 36 or the morning of day 37.
An injection of 5 iu eCG (Sigma Chemical Co, St Louis, MO) in 0.1 ml PBS was administered s.c. at 08:00 h to 28-day-old female rats in order to stimulate follicular development. Rats were decapitated and serum and ovaries were collected under aseptic conditions 0, 3, 24, 48, 51, 54, 57, 60 and 72 h after injection. A single injection of 10 iu hCG was administered 48 h after injection of eCG to induce ovulation. Controls were injected with 0.1 ml PBS using the same schedule as for the eCG and hCG injections.
Ovaries and sera were collected from approximately six animals at each time point in the natural and eCG-stimulated cycles. Ovarian homogenates were prepared and stored at -20°C until assayed for TNF-. Blood was allowed to clot overnight at 4°C. The serum was then removed, centrifuged (1900 # for 20 min) to remove red blood cells, and stored at -20°C until assayed for TNF-. All TNF-samples from a given experiment were assayed in the same assay and after only one thaw. Animal studies were in accordance with the Institutional Animal Care and Use Committee guidelines.
L929 TNF-bioassay TNFbioactivity was determined by the ability to lyse actinomycin D-treated mouse L929 cells (CCLl from American Type Culture Collection) (Mosmann, 1983) . The number of viable cells was quantified by the colorimetrie method using 1 mg 3-(4,5-dimethylthiaszol-2-yl)-2,5-diphenyl tetrazolium bromide ml~( MTT), a yellow substrate which is converted to a blue product by mitochondrial enzymes that are only active in viable cells. The method used was as described Marcinkiewicz et al (1994) . Briefly, 40 000 cells per well in 100 µ medium (RPMI 1640, Sigma, St Louis, MO, containing 10% heat inactivated fetal bovine serum, 25 mmol Hepes 1-, 50 units penicillin ml-, and 50 µg streptomycin ml-) were added to 96-well flat-bottomed culture dishes. Standard TNFand samples were then added. After 16 h incubation at 37°C in 5% C02 and air, cell numbers were determined by 3 h incubation in MTT. The standard curve ranged from 0.1 to 10 pg ml~1. Recombinant rat TNFwas obtained from Genzyme Inc. (Cambridge, MA) and had an activity of 5 IO7 units mg-1. Each ovary was placed in 200 µ medium and homogenized for 20 s at room temperature to prepare the tissue for bioassay. The homogenate was then centrifuged at 10 000 g for 10 min. Supernatant fluid was collected and stored at -20°C. Validation of the TNF-bioassay for rat sera and ovaries was performed on selected samples by neutralizing TNF-bioactivity with a polyclonal antibody to human TNFpreviously shown to crossreact with rat TNF-(Sancho-Tello et al, 1993).
Protein assay
Protein assay was carried out according to the method of Bradford (1976).
Statistical analysis
Data were analysed by one way analysis of variance followed by Fisher's protected least significant difference test (Statview 512 + , Agoura Hills, CA). Differences were considered significant if < 0.05.
Results
Ovarian TNF-a Puberty and the first ovulation. Ovarian concentrations of TNFwere highest (approximately 1 fg µg~ ovarian protein) before vaginal opening and the first ovulation at puberty ( Fig. 1 ). After the first ovulation (day 37; ova present in oviducts) ovarian concentrations of bioactive TNFwere markedly reduced (0.09 fg µg ' ovarian protein). Ovarian concentrations of TNF-remained low during the 8 days after the first ovulation (Fig. 1 ). eCG stimulation. Ovarian concentrations of TNFwere highest (approximately 1.2 fg µg~o varian protein) before injection of eCG (Fig. 2 ). TNFconcentrations declined to approximately 0.4 fg µg~ protein 3 h after eCG and decreased further to < 0.1 fg µg~: protein 24 h after injection.
Ovarian TNFconcentrations remained low up to 48 h after eCG. hCG was administered 48 h after eCG and ovarian concentrations of TNF-increased gradually to a peak (approximately 0.5 fg µg~1 protein) 6 h after hCG, and then declined. Ovarian TNFconcentrations 24 h after hCG were higher compared with values directly before injection with hCG ( Fig. 2 ). TNFconcentrations in the ovaries of salineinjected control animals did not show the same changes as the eCG and hCG-treated animals (Table 1) . TNFconcentrations in Age of rats (days) from those in 28-day-old experimental animals before injection of eCG.
Serum TNF-a
Puberty and the first ovulation. Serum concentrations of TNF-before and after vaginal opening and the first ovulation did not vary (33-41-day-old animals) (Fig. 1 ). However, in 43-day-old animals serum TNFconcentrations increased. eCG stimulation. Serum concentrations of TNF-did not change during 48 h after injection with eCG (Fig. 2 ). However, serum concentrations of TNFincreased 3 h after hCG when compared with pre-hCG values at 0, 3 and 24 h. However, in contrast to ovarian TNF-, serum concentrations of TNFremained elevated until 9 h after hCG and then decreased (Fig. 2) .
Discussion
This is the first demonstration of alterations in ovarian TNFconcentrations in vivo. Ovarian concentrations of TNF-varied at puberty and in response to exogenous gonadotrophins. Ovarian TNFconcentrations were highest in immature ovaries of 28-day-old rats before injection of eCG and in 33-day-old rats just before vaginal opening and the first ovulation (28-day-old: 1.1 ± 0.256 fg TNF-µg_I protein;
33-day-old: 1.054 ± 0.262 fg TNFµg" : protein). Within 3 h after injection of eCG, ovarian TNFconcentrations declined rapidly and reached the lowest value 24 h after eCG. In the first natural cycle TNFconcentrations did not decline until after ovulation. The physiological significance of the decline in TNFmay be related to increased ovarian cAMP. The initial injection of eCG may be similar to the primary surge in LH that initiates the first ovulation and stimulates an increase in ovarian cAMP concentration (Richards, 1980 (TNF-) in equine chorionic gonadotrophin (eCG)-treated immature rats. A 5 iu injection of eCG was administered to 28-day-old rats and ovaries and sera were collected 0, 3, 24, 48, 51, 54, 57, 60 and 72 h later. A 10 iu injection of human chorionic gonadotrophin (hCG) was administered 48 h after eCG. = 6 in each group except the 0 and 3 h groups (n = 5 and 3, respectively). Bars with different letters are significantly different (P < 0.05) by Fisher's protected least significant difference test. (6) "Concentration in 28-day-old rats before injection with equine chorionic gonadotrophin (eCG) or saline. Animals were injected with human chorionic gonadotrophin 48 h after the eCG injection. Numbers of animals are shown in parentheses.
in control animals (Sancho-Tello et al, 1993) , indicating that the reduction in the number of ova shed is due to reduced numbers of developing follicles in response to eCG. Therefore, increased circulating concentrations of TNFsuppress ovarian responses to exogenous gonadotrophins.
Similar observations have been made in vitro as evidenced by TNFsuppression of FSH-induced aromatase in granulosa cells (Emoto and Baird, 1988) and TNFsuppression of LH-stimulated thecal androgen synthesis (Andreani el al, 1991; Zachow et al, 1992) . In addition, TNF-has been shown to induce apoptosis of cultured early antral rat follicles (Kaipia el al, 1996) . Elevated concentrations of TNFmay reduce development of these follicles by inducing apoptosis. There¬ fore, it is possible that injection of eCG causes a decline in TNFconcentration, a reduction in apoptosis and develop¬ ment of follicules to the preovulatory phase. In contrast, TNFincreases progesterone secretion by preovulatory follicles in vitro (Roby and Terranova, 1988, 1990; Brannstrom et al, 1993 ). In addition, TNFinteracts synergistically with LH in inducing follicular rupture in vitro (Brannstrom et al, 1995) . Therefore, TNFsuppresses gonadotrophin-induced steroido¬ genesis, and suppresses differentiation or induces apoptosis in ovarian cells from developing follicles, whereas in preovulatory follicles, TNFpromotes ovulation.
In the study of Sancho-Tello et al (1993) points (Sancho-Tello et al, 1993) . However, in the present study, bioactive TNFwas highest before eCG injection (0 h) relative to the other time points. The discrepancy in these results may be explained by the fact that TNF-a-positive cells in the study of Sancho-Tello et al (1993) did not include oocytic TNF-, whereas the bioassay used in the present study includes TNF-from all cellular sources in the ovary. Alterna¬ tively, the expression of immunoreactive TNFmay not correlate directly with the amount of bioactive TNF-. Regulation of TNFprotein occurs by both posttranscriptional and post-translational mechanisms (Beutler et al, 1992) . A recent study reported a reduction in TNF-bio¬ activity at the same time as an increase in TNFimmunoreactivity (Suffredini et al, 1995) . This was due to the presence of a soluble receptor that inhibited TNF-bioactivity but not TNF-immunoreactivity. The presence and regulation of soluble TNFreceptors and other factors such as the enzymic activation and inactivation of TNFin the ovary have not been investigated.
Ovarian and serum concentrations of TNF-increased after administration of exogenous hCG during the preovulatory period. Several studies have suggested that TNF-has a role in ovulation. Brannstrom et al. (1995) reported that the addition of either LH or TNFto perfused ovaries induced ovulation of less than three ova per ovary, whereas a combination of LH and TNF-induced ovulation of approximately 11 ova. TNFhas been shown to increase the expression of leucocyte functional antigen-3 (LFA-3), a ligand of CD-2 antigen that is a surface marker of T-lymphocytes, in human granulosa cells in vitro (Hattori et al, 1995) . Increased expression of LFA occurs in newly formed human corpora lutea (Hattori et al, 1995) suggesting that TNFis involved in increased expression of LFA-3 during ovulation. TNFincreases prostaglandin syn¬ thesis during incubation of preovulatory follicles (Brannstrom et al, 1993) and prostaglandins have been implicated as causal factors in follicular rupture associated with the LH surge on pro-oestrus (Espey, 1994) . In addition, TNFconcentrations increase in follicular fluid during the bovine cycle as ovulation approaches (Zolfi et al, 1990 ). In the present study, serum TNFconcentrations during the first natural ovulation remained low and did not change until day 43. Serum TNFconcentrations measured at day 43 were comparable to the concentrations after hCG administration in the induction of ovulation. This natural increase in serum TNFmay be related to an endogenous surge of LH. It has been demonstrated that nearly all cell types have the capacity to produce TNF-.
Therefore, an increase in serum TNFconcentrations at the first ovulation may also represent development or maturation of other cellular systems.
In summary, high TNFconcentrations were present in the ovary of immature rats. Treatment with eCG rapidly decreased ovarian TNFconcentrations in immature rat ovaries without alteration of serum TNFconcentrations. Similarly, ovarian TNFconcentrations decreased in pubertal rats after the first ovulation. However, ovarian and serum concentrations of TNF-increased during the preovulatory period after admin¬ istration of an ovulation-inducing injection of hCG. These results suggest that TNFis involved in follicular develop¬ ment and ovulation at puberty and in immature rats in which ovulation has been induced with gonadotrophins.
